How Are Glaucoma Patients Identified?

Journal of Glaucoma

Volumn 12, Issue 6, 2003, Pages 451-455

  Quigley, Harry A ^a,b   Jampel, Henry D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Diagnosis; Glaucoma; Intraocular pressure; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; GLAUCOMA; HEALTH CARE SYSTEM; HUMAN; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; VISUAL FIELD DEFECT;

AGED; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; FEMALE; GLAUCOMA, ANGLE-CLOSURE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MASS SCREENING; MIDDLE AGED; OCULAR HYPERTENSION; OPTIC DISK; OPTIC NERVE DISEASES; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; QUESTIONNAIRES; VISUAL FIELDS;

EID: 0344305398     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-200312000-00001     Document Type: Article

References (20)

1. Quigley HA. The number of persons with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
2. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressure. Am J Ophthalmol. 1998;126:487-497.
3. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trail determines that topical ocular hypertensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713.
4. Leske MC, Heijl A, Hussein M, et al. Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121:48-56.
5. Quigley HA. Current and future approaches to glaucoma screening. J Glaucoma. 1998;7:210-219.
6. Sommer A, Tielsch JM, Quigley HA, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: The Baltimore Eye Survey. Arch Ophthalmol. 1991;109:1090-1095.
7. Buhrmann RR, Quigley HA, Barron Y, et al. The prevalence of glaucoma in a rural east African population. Invest Ophthalmol Vis Sci. 2000;41:40-48.
8. Quigley HA, West SK, Rodriguez J, et al. The prevalance of glaucoma in a population-based study of Hispanics: proyecto Ver. Arch Ophthalmol. 2001;119:1819-1826.
9. Mitchell P, Smith W, Attebo K, et al. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology. 1996;103:1661-1669.
10. Dielemans I, Vingerling JR, Wolfs RCW, et al. The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. Ophthalmology. 1994;101:1851-1855.
11. Klein BEK, Klein R, Sponsel WE, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology. 1992;99:1499-1504.
12. Wensor MD, McCarty CA, Stanislavsky YL, et al. The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology. 1998;105:733-739.
13. Wang F, Ford D, Tielsch JM, et al. Undetected eye disease in a primary care clinic population. Arch Intern Med. 1994;154:1821-1828.
14. Orr P, Barron Y, Schein OD, et al. Eye care utilization by older Americans. The SEE project. Ophthalmology. 1999;106:904-909.
15. Quigley HA, Park CK, Tracey PA, et al. Community screening for eye disease by lay persons: the Hoffberger program. Am J Ophthalmol. 2002;133:386-392.
16. Broman AT, Munoz B, Rodriguez J, et al. The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER. Invest Ophthalmol Vis Sci. 2002;43:3393-3398.
17. Lee BL, Wilson MR. Health-related quality of life in patients with cataract and glaucoma. J Glaucoma. 2000;9:87-94.
18. Janz NK, Wren PA, Lichter PR, et al. Quality of life in newly diagnosed glaucoma patients: The Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2001;08:887-897.
19. Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123:894-900.
20. Harlow SD, Linet MS. Agreement between questionnaire data and medical records: the evidence for accuracy of recall. Am J Epidemiol. 1989;129:233-248.